Paolo F Caimi
17PUBLICATIONS
117CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Oct 22, 2024
Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysis.Amneet Bajwa, Qiuhong Zhao, Marcus Geer
|Apr 02, 2024
Allogeneic CAR T Cells: Complex Cellular Therapy Designs Test the Limits of Our Preclinical Models.Paolo F Caimi, Jan Joseph Melenhorst
|Mar 08, 2024
Lenalidomide, rituximab (R2), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma.Brian T Hill, Yanwen Chen, Deepa Jagadeesh
|Feb 26, 2024
In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine.Paolo F Caimi, Mehdi Hamadani, Carmelo Carlo-Stella
|Jan 22, 2024
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.Jennifer L Crombie, Tara Graff, Lorenzo Falchi
|Jan 03, 2024
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia.Leland L Metheny, Ronald Sobecks, Christina Cho
Pageof 3
Frequent Collaborators
4 joint publications
Pier Luigi Zinzani
4 joint publications
Brad S Kahl
3 joint publications
Mehdi Hamadani
3 joint publications
Juan Pablo Alderuccio
3 joint publications
Carmelo Carlo-Stella
3 joint publications
John Radford
2 joint publications
Marcos de Lima
2 joint publications
Narendranath Epperla
2 joint publications
Nancy L Bartlett
2 joint publications
Alex Herrera
